How Does Immune Tolerance Prevent Autoimmunity?

Immune tolerance is the biological mechanism that prevents the immune system from launching attacks against the body's own tissues while preserving its ability to defend against pathogens. It relies on a coordinated two-tiered defense system: central tolerance and peripheral tolerance. Central tolerance operates during early lymphocyte development within primary lymphoid organs, identifying and eliminating or reprogramming strongly self-reactive immune cells. Because central screening is not completely exhaustive, peripheral tolerance functions as a secondary checkpoint throughout the rest of the body to suppress, disable, or destroy any autoreactive lymphocytes that evade initial detection. Together, these complementary pathways prevent devastating autoimmune pathology.

Mechanisms of Central Tolerance

Central tolerance serves as the primary developmental filter for maturing lymphocytes. It occurs within specialized primary lymphoid organs: the thymus for T lymphocytes and the bone marrow for B lymphocytes.

Thymic Selection in T Cells

During T cell development, immature thymocytes undergo critical screening processes dictated by the affinity of their T-cell receptors (TCRs) for self-peptide-major histocompatibility complex (self-peptide-MHC) molecules presented on thymic epithelial cells and dendritic cells.

  1. Positive Selection: Immature double-positive (\(CD4^+CD8^+\)) thymocytes must recognize self-peptide-MHC complexes with low-to-moderate affinity. Those that fail to bind undergo death by neglect due to lack of survival signals.
  2. Negative Selection (Clonal Deletion): Thymocytes that bind self-peptide-MHC complexes with high affinity pose an immediate threat of autoimmunity. These high-affinity cells are induced to undergo programmed cell death (apoptosis).
  3. The Role of AIRE: For negative selection to be effective against tissue-specific antigens (such as insulin or thyroglobulin), thymic medullary epithelial cells express the Autoimmune Regulator (AIRE) transcription factor. AIRE promotes the ectopic expression of thousands of peripheral tissue-restricted antigens, enabling the deletion of autoreactive thymocytes before they enter circulation.
  4. Generation of Natural Regulatory T Cells (\(tT_{reg}\)): A subset of \(CD4^+\) thymocytes with intermediate-to-high affinity for self-antigens escapes deletion and instead differentiates into forkhead box P3 (\(FoxP3^+\)) regulatory T cells (\(T_{reg}\)), specialized cells that later help maintain peripheral tolerance.

Bone Marrow Selection in B Cells

B cell development in the bone marrow involves testing the specificity of the B-cell receptor (BCR) against soluble and membrane-bound self-antigens.

  1. Receptor Editing: When an immature B cell binds multivalent self-antigens with high affinity, developmental arrest occurs. The cell reactivates its recombination activating genes (\(RAG1\) and \(RAG2\)) to rearrange alternative light chains (\(\kappa\) or \(\lambda\)). If the new light chain eliminates self-reactivity, the cell survives and matures.
  2. Clonal Deletion: If receptor editing fails to eliminate high-affinity self-reactivity, the immature B cell undergoes apoptosis.
  3. Anergy: Immature B cells that encounter soluble, low-affinity self-antigens downregulate surface immunoglobulin M (\(IgM\)) expression and become functionally unresponsive (anergic), significantly reducing their circulating lifespan.

Mechanisms of Peripheral Tolerance

Despite the rigor of central tolerance, some mature, low-affinity or cross-reactive lymphocytes escape into the peripheral circulation. Peripheral tolerance mechanisms act as secondary safety catches in secondary lymphoid tissues and non-lymphoid organs.

Anergy via Lack of Co-stimulation

Activation of naive T cells requires two distinct signals:

  • Signal 1: The engagement of the TCR with its specific peptide-MHC complex.
  • Signal 2: Co-stimulatory signaling through receptor-ligand pairs, primarily CD28 on the T cell interacting with CD80 (B7-1) or CD86 (B7-2) on mature antigen-presenting cells (APCs).

Under non-inflammatory conditions, healthy tissue APCs express minimal or no CD80/CD86 molecules. When an autoreactive T cell recognizes a self-antigen without co-stimulation, intracellular signaling cascades are aborted, driving the cell into anergy—a long-lasting state of functional unresponsiveness characterized by an inability to produce interleukin-2 (\(IL-2\)).

Regulatory T Cell (\(T_{reg}\)) Suppression

Regulatory T cells play an indispensable role in actively suppressing autoreactive responses in the periphery. They exert control through multiple distinct pathways:

  • Cytokine Secretion: \(T_{reg}\) cells secrete immunosuppressive cytokines, including transforming growth factor-beta (\(TGF-\beta\)), interleukin-10 (\(IL-10\)), and interleukin-35 (\(IL-35\)), which inhibit the proliferation and effector functions of conventional T cells and APCs.
  • Metabolic Disruption: High expression of the high-affinity \(IL-2\) receptor subunit alpha (\(CD25\)) on \(T_{reg}\) cells allows them to act as an \(IL-2\) sink, depriving autoreactive effector T cells of necessary survival and proliferation signals.
  • Surface-Mediated Inhibition: \(T_{reg}\) cells express Cytotoxic T-Lymphocyte-Associated Protein 4 (\(CTLA-4\)), which exhibits higher binding affinity for CD80 and CD86 than CD28. Through trans-endocytosis, \(CTLA-4\) strips co-stimulatory ligands from APC surfaces, preventing effective antigen presentation.

Inhibitory Immune Checkpoints

Mature effector lymphocytes express inhibitory receptors that deliver negative regulatory signals upon engagement with their ligands in peripheral tissues:

  • PD-1/PD-L1 Pathway: Programmed Cell Death Protein 1 (\(PD-1\)) expressed on activated lymphocytes binds to \(PD-L1\) and \(PD-L2\) on parenchymal and immune cells. This interaction recruits intracellular phosphatases (such as SHP-2) that dephosphorylate key downstream kinases of the TCR and CD28 cascades, blunting auto-aggressive immune responses.

Activation-Induced Cell Death (AICD)

Repeated or persistent stimulation of mature T cells by self-antigens in the absence of innate inflammatory signals triggers activation-induced cell death. This pathway is predominantly governed by the interaction between Fas (CD95) and Fas ligand (FasL), initiating the extrinsic caspase activation cascade and triggering apoptosis in chronic autoreactive cells.

Immunological Ignorance and Privileged Sites

Certain tissues, including the brain, anterior chamber of the eye, testicles, and placenta, are defined as immune-privileged sites. These tissues limit immune cell infiltration through physical barriers (such as the blood-brain barrier), active expression of FasL to induce apoptosis in infiltrating effector cells, and local production of immunosuppressive molecules. Lymphocytes capable of recognizing antigens in these regions typically remain ignorant of their existence unless severe physical trauma or infectious disruption breaches the barrier.

Summary of Tolerance Synergy

Central and peripheral tolerance form a multilayered continuum of immunological regulation. Central tolerance functions as a coarse developmental filter, purging the vast majority of highly autoreactive lymphocyte clones at their site of origin. Peripheral tolerance serves as an adaptable, continuous regulatory network that controls, silences, and eliminates any autoreactive lymphocytes that slip past the initial central checkpoints, thereby ensuring self-nonself discrimination and safeguarding the host against autoimmune diseases.